Anti-SARS-CoV-2 B and T-Cell Immune Responses Persist 12 Months After mRNA Vaccination with BNT162b2 in Systemic Lupus Erythematosus Patients Independently of Immunosuppressive Therapies

Anti-SARS-CoV-2 B and T-Cell Immune Responses Persist 12 Months After mRNA Vaccination with BNT162b2 in Systemic Lupus Erythematosus Patients Independently of Immunosuppressive Therapies

<b>Background:</b> In response to the SARS-CoV-2 pandemic, a massive vaccination campaign was launched. Nonetheless, concerns arose regarding some peculiar groups of patients, including those affected by Systemic Lupus Erythematosus (SLE), because of the immune-suppressive drugs routinel...

Full description

Saved in:
Bibliographic Details
Main Authors: Mario Ferraioli, Alessandra Aiello, Immacolata Prevete, Maria Sole Chimenti, Luigi De Marco, Silvia Meschi, Davide Mariotti, Valentina Vanini, Gilda Cuzzi, Andrea Salmi, Stefania Notari, Valeria Mellini, Vincenzo Puro, Fabrizio Maggi, Delia Goletti, Gian Domenico Sebastiani
Format: Article
Language:English
Published: MDPI AG 2025-04-01
Series:Vaccines
Subjects:
mRNA vaccine
vaccination
SLE
therapy
immune response
COVID-19
Online Access:https://www.mdpi.com/2076-393X/13/4/396
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.mdpi.com/2076-393X/13/4/396

Similar Items